TRV GP Vi, LLC

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 13, 2025), TRV GP Vi, LLC reported 4 stock positions worth $116.9 million. Its top holding was Septerna (SEPN) at 61.7% of the portfolio, followed by Cargo Therapeutics (CRGX, 23.0%) and Rapport Therapeutics (RAPP, 14.7%).

Most Recent 13F
Q2 2026
Location
Boston, MA
CIK
0001990716
Portfolio Value
$116.9M (Q4 2024)
SEC Filing
0000950123-25-002039 ↗ filed Feb 13, 2025

Holdings Value

0$50.0M$100.0M$150.0M$200.0M$250.0M Q4 2024: $116.9M $116.9M Q4 2024 Q1 2025: $42.0M Q1 2025 Q2 2025: $64.2M Q2 2025 Q3 2025: $109.6M Q3 2025 Q4 2025: $148.5M Q4 2025 Q1 2026: $135.6M Q1 2026 Q2 2026: $232.3M Q2 2026

Holdings 4 stocks · $116.9M
SEPN Septerna Inc. 61.75% 3,152,456 $72.2M —
CRGX Cargo Therapeutics Inc. 23.03% 1,867,119 $26.9M —
RAPP Rapport Therapeutics Inc. 14.71% 969,218 $17.2M —
TNGX Tango Therapeutics Inc. 0.51% 194,174 $600K —

Portfolio Sells Q4 2024

No earlier filing to compare with.

Portfolio Buys Q4 2024

No earlier filing to compare with.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 4$232.3MSEPN, SPTX, RAPP, TNGX
Q1 2026 3$135.6MSEPN, RAPP, TNGX
Q4 2025 3$148.5MSEPN, RAPP, TNGX
Q3 2025 3$109.6MSEPN, RAPP, TNGX
Q2 2025 4$64.2MSEPN, RAPP, CRGX, TNGX
Q1 2025 4$42.0MSEPN, RAPP, CRGX, TNGX
Q4 2024 4$116.9MSEPN, CRGX, RAPP, TNGX